![Real-world tumor response rate can serve as a clinical endpoint, Friends pilot study shows FDA says raw images enrich the data when used with clinician assessments](https://cdn.cancerletter.com/media/2023/10/06150627/49-37-4x3-1.jpg)
![Real-world tumor response rate can serve as a clinical endpoint, Friends pilot study shows FDA says raw images enrich the data when used with clinician assessments](https://cdn.cancerletter.com/media/2023/10/06150627/49-37-4x3-1.jpg)
Cover Story
ClinicalReal-world Evidence
A novel study led by Friends of Cancer Research is providing evidence that tumor response rates can be assessed across real-world data sets, bringing regulators one step closer to potentially building a framework for pre-market evaluation of cancer drugs and post-market tracking of drug performance based on real-world endpoints.
In Brief
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
Clinical Roundup
![Clinical Roundup](https://cdn.cancerletter.com/media/2019/05/03161627/clinical_roundup.jpg)
![Clinical Roundup](https://cdn.cancerletter.com/media/2019/05/03161627/clinical_roundup.jpg)
Drugs & Targets
![Drugs & Targets](https://cdn.cancerletter.com/media/2019/05/03161633/targets2.jpg)
![Drugs & Targets](https://cdn.cancerletter.com/media/2019/05/03161633/targets2.jpg)
NCI Trials
![NCI Trials](https://cdn.cancerletter.com/media/2019/05/03161630/CTEP.jpg)
![NCI Trials](https://cdn.cancerletter.com/media/2019/05/03161630/CTEP.jpg)
NCI Trials for October 2023
The National Cancer Institute approved the following clinical research studies last month.
Trending Stories
- Edward Sondik, electrical engineer turned public health expert and one-time interim NCI director, dies at 82
- In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
- Trump et al. are wrong: Biden Cancer Initiative is not to be confused with the Beau Biden Cancer Moonshot
- NCI’s Virtual Clinical Trials Office fills the staffing shortages at cancer centers
- Elizabeth Comen joins NYU Langone Health’s Perlmutter Cancer Center
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission